Medigus to Present at the Innovation in Gastroenterology, 2017 Symposium

OMER, Israel, January 3, 2017 – Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, announced today that Yaron Silberman, PhD, Vice President of Sales and Marketing, will present the Medigus Ultrasonic Surgical Endostapler, or MUSE™ system during the Inventors Corner Session at the Innovation in Gastroenterology, 2017 Symposium, on January 4, 2017 at 5:50pm Israel time (UTC/GMT +2 hours). The conference will take place at the Hilton Hotel, Tel Aviv, Israel from January 4-6, 2017.

The Inventors Corner Session will provide a forum for physicians and researchers to meet entrepreneurs, investors, hedge-fund representatives and well-established pharmaceutical companies to share innovations, daily clinical knowledge and cutting-edge developments and the latest advances of clinical management in the field of gastroenterology.

Silberman will present MUSE, a comprehensive device which incorporates microvisual, ultrasonic and surgical stapling capability. The device allows a single physician or surgeon to perform fundoplication (stapling of the upper part of the stomach to the lower esophageal sphincter) transorally (without incisions). Since the device doesn’t require any incisions, patients generally report greater comfort during the procedure and experience reduced hospital stays by up to 50% over invasive fundoplication procedures.

Innovation in Gastroenterology attendees can learn more about the MUSE system by visiting

Innovation in Gastroenterology, 2017 Symposium
This will be an exclusive event where gastroenterologists, researchers, and the pharmaceutical industry from all over the world can meet and learn about novel emerging technologies as well as practical gastroenterology and hepatology.